Founded to serve health, Servier is a global group governed by a Foundation that aspires to have a meaningful social impact, both for patients and for a sustainable world. With its unique governance model, it can fully serve its vocation with a long-term vision: being committed to therapeutic progress to serve patient needs. The 21,900 employees of the Group are committed to this shared vocation, source of inspiration every day. As a world leader in cardiology, Servier's ambition is to become a focused and innovative player in oncology by targeting hard-to-treat cancers. That is why the Group allocates over 70% of its R&D budget to developing targeted and innovative therapies in oncology. Neuroscience and immuno-inflammatory diseases are the future growth drivers. In these areas, Servier is focused on a limited number of diseases in which accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote access to quality care for all at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, relying on strong brands in France, Eastern Europe, Brazil and Nigeria. In all these areas, the Group includes the patient voice at each stage of the life cycle of a medicine. Headquartered in France, Servier relies on a strong geographical footprint in over 150 countries and achieved a revenue of €5.3 billion in 2023. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Website: https://servier.com

Employees: 12175

HQ: (647) 798-0420

Location: Boston, MA, US

Revenue: $3.5 billion

Servier is a global pharmaceutical company that focuses on developing and commercializing innovative therapeutic solutions. With a presence in over 140 countries, Servier is committed to improving the health and well-being of people around the world. If you're looking for contact information for Servier, ConnectPlex is the right place to be. Our B2B lead generation platform provides access to millions of company records, including key contact information for Servier and other pharmaceutical companies. At ConnectPlex, we understand the importance of connecting with the right people in the industry. That's why we've developed a powerful search engine that allows you to find and connect with professionals in any company, including Servier. With our platform, you can easily find contact information for decision-makers, executives, and other key personnel in Servier and related companies. Whether you're looking to collaborate, partner, or do business with Servier, ConnectPlex is the perfect starting point for your search.

Servier is a global pharmaceutical group that is governed by a Foundation and has a strong presence in 150 countries. With a revenue of 4.7 billion euros in 2021, the company employs 21,800 people worldwide. Servier is committed to investing over 20% of its brand-name revenue in Research and Development every year, with a focus on cardiovascular and metabolic diseases, oncology, neuroscience, and immuno-inflammatory diseases. The company's ambition is to become a renowned and innovative player in oncology, while also offering a range of quality generic drugs to promote access to healthcare for all. Servier has a strong commitment to open and collaborative innovation, working with academic partners, pharmaceutical groups, and biotech companies to accelerate therapeutic innovation for the benefit of patients. The company also integrates the patient's voice at the heart of its activities. With a calculated domain of servier.com, the company's phone number is 800-807-6124, and its Facebook URL is https://www.facebook.com/servierinternational. Servier's location is 200 Pier Four Boulevard, Boston, MA 02210, and its LinkedIn URL is http://www.linkedin.com/company/servier. The company's leadership team includes Arnaud Lallouette, CEO of Servier Australia, Andrey Khudentsov, BD&CMO manager, Umer Tariq, Executive Assistant to the Chief Executive Officer, Hubert Tournier, Group Chief Information Officer, and Sophie Ollivier, Chief Data Officer. Servier's SIC definitions include Pharmaceutical Preparations, and the company's tags include Medication for cardiological and rheumatological conditions, as well as for diabetes and clinical depression.

Servier is a global pharmaceutical company that is owned by a foundation. They have a strong presence in 150 countries and make a total of 4.7 billion euros in revenue each year. They employ 21,800 people around the world. Servier invests a significant amount of their revenue into research and development every year. They work with universities, other pharmaceutical companies, and biotech companies to develop new treatments for patients. They also make sure to include the patient's perspective in their work. Servier is a leader in cardiology and wants to become a leader in oncology. They focus on treating cardiovascular and metabolic diseases, oncology, neuroscience, and immuno-inflammatory diseases. They also offer a range of generic drugs that are available to treat many different conditions. If you suspect that you have experienced a side effect from a Servier drug, you can report it on their website, servier.com.